Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:approvedBy |
gptkb:FDA
2017 |
| gptkbp:ATCCode |
J01MA23
|
| gptkbp:CASNumber |
189279-58-1
|
| gptkbp:contraindication |
hypersensitivity to fluoroquinolones
|
| gptkbp:drugClass |
fluoroquinolone
|
| gptkbp:genericName |
delafloxacin
|
| https://www.w3.org/2000/01/rdf-schema#label |
Baxdela
|
| gptkbp:indication |
gptkb:community-acquired_bacterial_pneumonia
acute bacterial skin and skin structure infections |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Melinta_Therapeutics
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
diarrhea headache transaminase increased |
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:bfsParent |
gptkb:Takeda_(in_Japan)
gptkb:Melinta_Therapeutics |
| gptkbp:bfsLayer |
7
|